NFCR Writer David Perry, Author at NFCR - Page 2 of 9

NFCR Writer David Perry

Origin Cells of Glioblastoma May Have Been Identified

In what could be a major breakthrough, scientists at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea claim to have identified the cellular origin of glioblastoma, a fast-growing type of central nervous system tumor that forms from supportive tissue of the brain and spinal cord. It…...

Read more

At Its Root

Chaos can be surprisingly orderly. While cancer is characterized by uncontrolled cell growth, that growth is, nevertheless, the result of a very particular cascade of events, from carcinogen exposure to genetic mutations. Interfere with that cascade, and cancer can be ground to a halt, or even killed off. The efforts…...

Read more

New Therapies Aim to Lessen Side Effects in Children

Ask any parent about their child fighting cancer and words like “nightmare” and “helpless” will almost certainly be part of the conversation. Within pediatric cancer medicine, the entire field faces the brutal reality that chemotherapy, surgery and most other cancer treatments are not designed for children. This can be somewhat…...

Read more

Ronald DePinho: The Age of Cancer

“For me, this is one of the great honors of my research career,” says Dr. Ronald DePinho, who in 2009 won the prestigious Szent-Györgyi Prize for Progress in Cancer Research—and who has a touching personal tie to the namesake of the accolade. “I had the privilege of meeting Dr. Szent-Györgyi…...

Read more

Showing Promise: Confronting Brain Cancer in the Lab

Any brain cancer surgery carries significant risk. For one, post-procedural swelling can be deadly. Doctors must also take into account the size of the tumor, its type and grade, the location and whether or not it is pressing against a vital part of the brain. Moreover, the brain is the…...

Read more

Labs Navigate the “Valley of Death”

Here is the hard truth: Research is expensive. Salaries, equipment, upgrades, experiments, clinical trials and prototyping voraciously eat up budgets, even those in the tens or hundreds of millions of dollars. And this is before success (or failure) is declared. Unfortunately, just because a cancer laboratory gets a grant from…...

Read more

Ancient Wisdom, Modern Cure

“Chinese traditional medicine” (TCM) is a cultural catch-all term for a series of practices including herbal medicine, diet, acupuncture, massage and exercise (like tai chi) whose combined history stretches back over four thousand years. Western science acknowledges the benefits of some forms of TCM — acupuncture and Chinese massage techniques,…...

Read more

Inexpensive Tests Spur Family Members to Assess Cancer Risks

As technology improves and costs come down, medical practitioners are noticing a new trend: family members of cancer patients are now asking for their genomes to be profiled in order to gauge their risks of developing the disease. This assertion is backed by a Stanford University study of more than…...

Read more

Shining a Light (on Tumors)

There is a necessary truth about a surgical procedure: It’s not “neat.” There will be blood. There will be stitches. There will be some pain, discomfort and a recovery period. In the case of cancer, there might also be a second surgery. “When surgeons go in to remove a cancer,…...

Read more

Kidney Cancer Detection Advances

About 73,820 new cases of kidney cancer are forecast to be diagnosed among Americans in 2019, and nearly 14,770 can be expected to die from the disease. Cancer of the kidneys, like any cancer, is most curable at an early stage. However, the majority of early-stage tumors do not present…...

Read more